References
- Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005;65:9603–6.
- Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, Kojima T, Tight junctions and human diseases. Med Electron Microsc 2003;36:147–56.
- Al Moustafa AE, Alaoui–Jamali MA, Batist G, Hernandez–Perez M, Serruya C, Alpert L, Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;21:2634–40.
- Usami Y, Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N, Reduced expression of claudin–7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 2006;37:569–77.
- Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T. Tight junction protein claudin–1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin–5 gamma2 chain via matrix metalloproteinase (MMP)–2 and membrane–type MMP–1. Cancer Res 2006;66:5251–7.
- Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005;171:939–45.
- Ikenouchi J, Sasaki H, Ysukita S, Furuse M, Tsukita S. Loss of occludin affects tricellular localization of tricellulin. Mol Biol Cell 2008;19:4687–93.
- D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944–6.
- Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709–20.
- Go M, Kojima T, Takano K, Murata M, Ichimiya S, Tsubota H, Expression and function of tight junctions in the crypt epithelium of human palatine tonsils. J Histochem Cytochem 2004;52:1627–38.
- Takano K, Kojima T, Ogasawara N, Go M, Kikuchi S, Ninomiya T, Expression of tight junction proteins in epithelium including Ck20–positive M–like cells of human adenoids in vivo and in vitro. J Mol Histol 2008;39:265–73.
- Ohkuni T, Kojima T, Ogasawara N, Masaki T, Ninomiya T, Kikuchi S, Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitro. Med Mol Morphol 2009;42:204–11.
- Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Loss of the tight junction protein claudin–7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003;22:2021–33.
- Kuhn S, Koch M, Nübel T, Ladwein M, Antolovic D, Klingbeil P, A complex of EpCAM, claudin–7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 2007;5:553–67.
- Nübel T, Preobraschenski J, Tuncay H, Weiss T, Kuhn S, Ladwein M, Claudin–7 regulates EpCAM–mediated functions in tumor progression. Mol Cancer Res 2009;7:285–99.
- Hirohashi S. Inactivation of the E–cadherin–mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333–9.
- Gröne J, Weber B, Staub E, Heinze M, Klaman I, Pilarsky C, Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin–1, –8 and –12. Int J Colorectal Dis 2007;22:651–9.
- Tan X, Egami H, Ishikawa S, Kurizaki T, Nakagawa M, Hirota M, Arrangement of expression and distribution of tight junction protein claudin–1 in cell dissociation of pancreatic cancer cells. Int J Oncol 2004;25:1567–74.
- Agarwal R, D'Souza T, Morin PJ. Claudin–3 and claudin–4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase–2 activity. Cancer Res 2005;65:7378–85.
- Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y. Involvement of claudin–1 in the beta–catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 2001;12:469–76.
- Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Claudin–1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005;115:1765–76.
- Yang F, Zeng Q, Yu G, Li S, Wang CY. Wnt/beta–catenin signaling inhibits death receptor–mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal 2006;18:679–87.